Focus Area Corporate Partnering & Strategy

The Client

  • US-based biotech with a portfolio of CNS gene therapies in early-stage development for neurodegenerative diseases, neurodevelopmental disorders, and genetic epilepsies


  • The biotech was looking to capitalize on a sudden surge of pharma interest in neurology to facilitate favorable deal terms on a pre-IND gene therapy program
  • The company needed to quickly gather the necessary materials and information in order to pitch and value their program and respond to in-bound interest


  • Held discussions with internal commercial and R&D stakeholders to determine value proposition & align on partnering strategy
  • Performed a deal benchmarking analysis to uncover the defensible deal value in the relevant indication
  • Identified qualified partners and socialized the product concept to solicit feedback and gauge partnering interest

Valued Outcome

  • Instilled readiness to engage with potential partners, including guidance on deal value/structure, development of pitch deck and term sheet, and insights for successful partnering and deal negotiation
  • ID’d and obtained feedback from target partners
  • Helped elucidate the value proposition and anticipate and address likely due diligence questions